Albumin therapy enhances collateral perfusion after laser-induced middle cerebral artery branch occlusion: A laser speckle contrast flow study

Richard A. Defazio, Weizhao Zhao, Xiaolu Deng, Andre Obenaus, Myron Ginsberg

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Laser speckle contrast (LSC) was used to compare the extent of cortical ischemia in two inbred mouse strains that differed in their degree of collateral circulation, after laser occlusion of the distal middle cerebral artery, and after treatment with 25% albumin (ALB) or saline (control). Sequential LSC images acquired over 90 minutes were coaligned, converted to relative flow, and normalized to baseline. After 3-day survival, infarction was quantified by triphenyl tetrazolium chloride or magnetic resonance imaging. In the sparsely collateralized BALB/c strain, mean flow fell to 13% to 14% and 33% to 34% of baseline in central (core) and peripheral (penumbral) regions of interest, and ALB treatment at 30 minutes enhanced perfusion in both regions by ∼ 2-fold relative to saline, restoring flow to the benign-oligemic range centrally, and to the hyperemic range peripherally. The ALB-induced increment in parenchymal perfusion was disproportionate to the subtle flow increase in the occluded artery itself, suggesting that ALB improved collateral circulation. Cortical infarction in BALB/c mice was reduced 45% by ALB treatment. In contrast to BALB/c mice, the better-collateralized CD-1 strain developed milder ischemia, had smaller infarcts, and showed no differential benefit of ALB. We conclude that where native collateralization is insufficient (BALB/c strain), ALB treatment exerts a significant therapeutic effect after ischemia by augmenting collateral perfusion.

Original languageEnglish
Pages (from-to)2012-2022
Number of pages11
JournalJournal of Cerebral Blood Flow and Metabolism
Volume32
Issue number11
DOIs
StatePublished - Nov 1 2012

Fingerprint

Middle Cerebral Artery Infarction
Albumins
Lasers
Perfusion
Collateral Circulation
Ischemia
Infarction
Therapeutics
Inbred Strains Mice
Therapeutic Uses
Chlorides
Arteries
Magnetic Resonance Imaging

Keywords

  • collateral circulation
  • focal cerebral ischemia
  • hemodynamics
  • neuroprotection
  • reperfusion

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Clinical Neurology
  • Neurology

Cite this

Albumin therapy enhances collateral perfusion after laser-induced middle cerebral artery branch occlusion : A laser speckle contrast flow study. / Defazio, Richard A.; Zhao, Weizhao; Deng, Xiaolu; Obenaus, Andre; Ginsberg, Myron.

In: Journal of Cerebral Blood Flow and Metabolism, Vol. 32, No. 11, 01.11.2012, p. 2012-2022.

Research output: Contribution to journalArticle

@article{f58284fc2ff34900b514feafd9231549,
title = "Albumin therapy enhances collateral perfusion after laser-induced middle cerebral artery branch occlusion: A laser speckle contrast flow study",
abstract = "Laser speckle contrast (LSC) was used to compare the extent of cortical ischemia in two inbred mouse strains that differed in their degree of collateral circulation, after laser occlusion of the distal middle cerebral artery, and after treatment with 25{\%} albumin (ALB) or saline (control). Sequential LSC images acquired over 90 minutes were coaligned, converted to relative flow, and normalized to baseline. After 3-day survival, infarction was quantified by triphenyl tetrazolium chloride or magnetic resonance imaging. In the sparsely collateralized BALB/c strain, mean flow fell to 13{\%} to 14{\%} and 33{\%} to 34{\%} of baseline in central (core) and peripheral (penumbral) regions of interest, and ALB treatment at 30 minutes enhanced perfusion in both regions by ∼ 2-fold relative to saline, restoring flow to the benign-oligemic range centrally, and to the hyperemic range peripherally. The ALB-induced increment in parenchymal perfusion was disproportionate to the subtle flow increase in the occluded artery itself, suggesting that ALB improved collateral circulation. Cortical infarction in BALB/c mice was reduced 45{\%} by ALB treatment. In contrast to BALB/c mice, the better-collateralized CD-1 strain developed milder ischemia, had smaller infarcts, and showed no differential benefit of ALB. We conclude that where native collateralization is insufficient (BALB/c strain), ALB treatment exerts a significant therapeutic effect after ischemia by augmenting collateral perfusion.",
keywords = "collateral circulation, focal cerebral ischemia, hemodynamics, neuroprotection, reperfusion",
author = "Defazio, {Richard A.} and Weizhao Zhao and Xiaolu Deng and Andre Obenaus and Myron Ginsberg",
year = "2012",
month = "11",
day = "1",
doi = "10.1038/jcbfm.2012.102",
language = "English",
volume = "32",
pages = "2012--2022",
journal = "Journal of Cerebral Blood Flow and Metabolism",
issn = "0271-678X",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Albumin therapy enhances collateral perfusion after laser-induced middle cerebral artery branch occlusion

T2 - A laser speckle contrast flow study

AU - Defazio, Richard A.

AU - Zhao, Weizhao

AU - Deng, Xiaolu

AU - Obenaus, Andre

AU - Ginsberg, Myron

PY - 2012/11/1

Y1 - 2012/11/1

N2 - Laser speckle contrast (LSC) was used to compare the extent of cortical ischemia in two inbred mouse strains that differed in their degree of collateral circulation, after laser occlusion of the distal middle cerebral artery, and after treatment with 25% albumin (ALB) or saline (control). Sequential LSC images acquired over 90 minutes were coaligned, converted to relative flow, and normalized to baseline. After 3-day survival, infarction was quantified by triphenyl tetrazolium chloride or magnetic resonance imaging. In the sparsely collateralized BALB/c strain, mean flow fell to 13% to 14% and 33% to 34% of baseline in central (core) and peripheral (penumbral) regions of interest, and ALB treatment at 30 minutes enhanced perfusion in both regions by ∼ 2-fold relative to saline, restoring flow to the benign-oligemic range centrally, and to the hyperemic range peripherally. The ALB-induced increment in parenchymal perfusion was disproportionate to the subtle flow increase in the occluded artery itself, suggesting that ALB improved collateral circulation. Cortical infarction in BALB/c mice was reduced 45% by ALB treatment. In contrast to BALB/c mice, the better-collateralized CD-1 strain developed milder ischemia, had smaller infarcts, and showed no differential benefit of ALB. We conclude that where native collateralization is insufficient (BALB/c strain), ALB treatment exerts a significant therapeutic effect after ischemia by augmenting collateral perfusion.

AB - Laser speckle contrast (LSC) was used to compare the extent of cortical ischemia in two inbred mouse strains that differed in their degree of collateral circulation, after laser occlusion of the distal middle cerebral artery, and after treatment with 25% albumin (ALB) or saline (control). Sequential LSC images acquired over 90 minutes were coaligned, converted to relative flow, and normalized to baseline. After 3-day survival, infarction was quantified by triphenyl tetrazolium chloride or magnetic resonance imaging. In the sparsely collateralized BALB/c strain, mean flow fell to 13% to 14% and 33% to 34% of baseline in central (core) and peripheral (penumbral) regions of interest, and ALB treatment at 30 minutes enhanced perfusion in both regions by ∼ 2-fold relative to saline, restoring flow to the benign-oligemic range centrally, and to the hyperemic range peripherally. The ALB-induced increment in parenchymal perfusion was disproportionate to the subtle flow increase in the occluded artery itself, suggesting that ALB improved collateral circulation. Cortical infarction in BALB/c mice was reduced 45% by ALB treatment. In contrast to BALB/c mice, the better-collateralized CD-1 strain developed milder ischemia, had smaller infarcts, and showed no differential benefit of ALB. We conclude that where native collateralization is insufficient (BALB/c strain), ALB treatment exerts a significant therapeutic effect after ischemia by augmenting collateral perfusion.

KW - collateral circulation

KW - focal cerebral ischemia

KW - hemodynamics

KW - neuroprotection

KW - reperfusion

UR - http://www.scopus.com/inward/record.url?scp=84868513513&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868513513&partnerID=8YFLogxK

U2 - 10.1038/jcbfm.2012.102

DO - 10.1038/jcbfm.2012.102

M3 - Article

C2 - 22781334

AN - SCOPUS:84868513513

VL - 32

SP - 2012

EP - 2022

JO - Journal of Cerebral Blood Flow and Metabolism

JF - Journal of Cerebral Blood Flow and Metabolism

SN - 0271-678X

IS - 11

ER -